Siemens – Merck and Siemens deepen strategic partnership to accelerate AI and data-driven drug discovery and development

• MoU signed to deliver end-to-end digital workflows from drug discovery to manufacturing through combination of technology from the Siemens Xcelerator platform and Merck’s Life Sciences portfolio
• Joint projects include developing AI-driven tools and digital interfaces that simplify complex scientific processes

Merck and Siemens have signed a new Memorandum of Understanding (MoU), extending their strategic partnership to accelerate digital transformation in the life science industry by connecting digital and physical products. The agreement focuses on delivering integrated software solutions, systems and consumables that harness automation, data and AI to connect drug discovery, development, and manufacturing.

…